Home/Filings/4/0001126234-21-000009
4//SEC Filing

Langren Carl W. 4

Accession 0001126234-21-000009

CIK 0001126234other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 6:51 PM ET

Size

8.7 KB

Accession

0001126234-21-000009

Insider Transaction Report

Form 4
Period: 2021-02-01
Langren Carl W.
Principal Accounting Officer
Transactions
  • Award

    Common Stock

    2021-02-01+93912,177 total
  • Award

    Stock Option (Right to Buy)

    2021-02-01+11,47511,475 total
    Exercise: $17.35Exp: 2031-01-31Common Stock (11,475 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    5,521
Footnotes (3)
  • [F1]Represents shares issued as restricted stock units ("RSUs") under the Issuer's 2009 Equity Incentive Plan, as amended, (the "Plan") that were received as an award, for no consideration. The RSUs vest in a series of four successive annual installments beginning on February 1, 2022, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
  • [F2]Includes 9,000 RSUs previously reported as holdings of the Reporting Person granted under the Plan. The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments with the next installment occurring on April 1, 2021, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
  • [F3]Grant to the Reporting Person of a stock option under the Plan. The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on March 1, 2021, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan. The option expires ten years after the date of grant.

Issuer

LUMOS PHARMA, INC.

CIK 0001126234

Entity typeother

Related Parties

1
  • filerCIK 0001591245

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 6:51 PM ET
Size
8.7 KB